Literature DB >> 29931541

Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation.

Yasushi Wakabayashi1, Takeshi Mitsuhashi2, Naoyuki Akashi2, Takekuni Hayashi2, Tomio Umemoto2, Yoshitaka Sugawara2, Hideo Fujita2, Shin-Ichi Momomura2.   

Abstract

Previous studies suggested that right ventricular pacing was associated with pacing-induced cardiac dysfunction (PICD). The purpose of this study was to investigate the clinical characteristics including the incidence of undiagnosed cardiac sarcoidosis (CS) in patients with atrioventricular block (AVB) who manifest PICD. We retrospectively investigated consecutive patients with permanent pacemaker (PPM) undergoing a first-generator replacement surgery with a new PPM or an upgrade procedure to a cardiac resynchronization therapy (CRT) device between December 1, 2011 and June 30, 2017. Patients with AVB showing normal echocardiographic findings before PPM implantation were included and divided into 2 groups: patients with post-PPM left ventricular ejection fraction (LVEF) < 40% and/or undergoing an upgrade procedure to CRT (PICD group) and patients with post-PPM LVEF ≥ 40% who underwent replacement surgery with a new PPM (no-PICD group). There were 15 and 41 patients in the PICD and no-PICD groups, respectively. A wider-paced QRS duration just after the PPM implantation and/or lower pre-PPM LVEF was observed in the PICD group. Furthermore, 46.7% of the PICD patients (7/15) satisfied the diagnostic criteria for CS according to the guideline of the Japanese Circulation Society, although no patients fulfilled these criteria before PPM implantation. In conclusion, a high incidence of CS was observed in patients with AVB who had PICD. However, none of these patients was diagnosed with CS before PPM implantation.

Entities:  

Keywords:  Cardiac resynchronization therapy; Cardiac sarcoidosis; Pacing-induced cardiac dysfunction; Permanent pacemaker

Mesh:

Year:  2018        PMID: 29931541     DOI: 10.1007/s00380-018-1206-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  18 in total

1.  Evidence of left ventricular dyssynchrony resulting from right ventricular pacing in patients with severely depressed left ventricular ejection fraction.

Authors:  Martin Schmidt; Jürgen Brömsen; Christian Herholz; Kai Adler; Florian Neff; Carsten Kopf; Michael Block
Journal:  Europace       Date:  2007-01       Impact factor: 5.214

2.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

3.  Paced QRS duration as a predictor for clinical heart failure events during right ventricular apical pacing in patients with idiopathic complete atrioventricular block: results from an observational cohort study (PREDICT-HF).

Authors:  Shaojie Chen; Yuehui Yin; Xianbin Lan; Zengzhang Liu; Zhiyu Ling; Li Su; Márcio Galindo Kiuchi; Xiaoli Li; Bin Zhong; Mitchell W Krucoff
Journal:  Eur J Heart Fail       Date:  2012-12-28       Impact factor: 15.534

4.  Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function.

Authors:  Erich L Kiehl; Tarek Makki; Rahul Kumar; Divya Gumber; Deborah H Kwon; John W Rickard; Mohamed Kanj; Oussama M Wazni; Walid I Saliba; Niraj Varma; Bruce L Wilkoff; Daniel J Cantillon
Journal:  Heart Rhythm       Date:  2016-12       Impact factor: 6.343

5.  A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy.

Authors:  Hossein Ardehali; David L Howard; Arvin Hariri; Atif Qasim; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

6.  Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing.

Authors:  Fumito Miyoshi; Youichi Kobayashi; Hiroyuki Itou; Tatsuya Onuki; Takaaki Matsuyama; Norikazu Watanabe; Chungchang Liu; Mitsuharu Kawamura; Taku Asano; Akira Miyata; Haruyuki Nakagawa; Kaoru Tanno; Takao Baba; Takashi Katagiri
Journal:  Pacing Clin Electrophysiol       Date:  2005-11       Impact factor: 1.976

Review 7.  Cardiac Sarcoidosis.

Authors:  David H Birnie; Pablo B Nery; Andrew C Ha; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2016-07-26       Impact factor: 24.094

8.  Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy.

Authors:  Shaan Khurshid; Jackson J Liang; Anjali Owens; David Lin; Robert Schaller; Andrew E Epstein; Francis E Marchlinski; David S Frankel
Journal:  J Cardiovasc Electrophysiol       Date:  2016-08-19

9.  Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.

Authors:  Michael O Sweeney; Anne S Hellkamp; Kenneth A Ellenbogen; Arnold J Greenspon; Roger A Freedman; Kerry L Lee; Gervasio A Lamas
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

10.  Incidence and predictors of right ventricular pacing-induced cardiomyopathy.

Authors:  Shaan Khurshid; Andrew E Epstein; Ralph J Verdino; David Lin; Lee R Goldberg; Francis E Marchlinski; David S Frankel
Journal:  Heart Rhythm       Date:  2014-06-02       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.